ARTICLE
11 February 2026

AG Coalition Reaches $17.85M Settlement In Generic Drug Pricing Antitrust Litigation

CO
Cozen O'Connor

Contributor

Founded in 1970, Cozen O’Connor has more than 925 attorneys practicing internationally in 32 cities across North America and Europe. We are a full-service firm with award-winning practices in litigation, business law, and government relations, and our attorneys have experience operating in all sectors of the economy. Our diverse client list includes global Fortune 500 companies, middle-market firms poised for growth, ambitious startups, and high-profile individuals.

A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. ("Lannett")...
United States Connecticut Antitrust/Competition Law
Cozen O'Connor’s articles from Cozen O'Connor are most popular:
  • with readers working within the Property industries
Cozen O'Connor are most popular:
  • within Intellectual Property and Family and Matrimonial topic(s)

Source: The State AG Report

State: Connecticut, Multistate

Industry: Healthcare, Pharmaceuticals

Area of Law: Consumer Protection

  • A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. ("Lannett") and Bausch Health US, LLC/Bausch Health Americas, Inc. ("Bausch") in generic-drug antitrust litigation.
  • The states allege the companies participated in long-running conspiracies to fix prices and otherwise restrain competition in the generic drug market, including through coordination with competitors.
  • Under the terms of the settlements—subject to court approval—Lannett will pay $13.77 million toward restitution and costs and agrees to a 10-year antitrust compliance program; Bausch will pay $4.08 million toward restitution and costs and must maintain an antitrust compliance policy and conduct annual antitrust training for four years. Both companies must provide reasonable cooperation with the states in the ongoing litigation against non-settling defendants.
  • AG Tong separately announced that his office and 42 states and territories are also filing a new lawsuit against Novartis and its subsidiaries Sandoz Group AG and Sandoz AG alleging similar conduct.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More